Trials / Conditions / Vascular Disease, Peripheral

Vascular Disease, Peripheral

16 registered clinical trials studyying Vascular Disease, Peripheral — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Clinical Outcomes, Safety, and Cost-Effectiveness Analysis of Two Catheters (Xianrui Da and Medtronic) in Radi NCT07046286	Chengdu University of Traditional Chinese Medicine	N/A
Recruiting	Correlating Multispectral Near-Infrared Imaging to Standard Vascular Diagnostics NCT06899113	MIMOSA Diagnostics Inc.	—
Recruiting	Observation of Pain During the Treatment of Great Saphenous Vein Using Microwave Ablation， and Analysis of Rel NCT06693245	Chengdu University of Traditional Chinese Medicine	—
Recruiting	Comparative Analysis of Radiofrequency Ablation and Microwave Ablation Procedures for the Treatment of Small S NCT06711120	Chengdu University of Traditional Chinese Medicine	N/A
Completed	Brain Vascular and Neurocognitive Health NCT06497413	The University of Texas at Arlington	N/A
Withdrawn	Immunomodulatory Effects of PCSK9 Inhibition NCT05720156	Massachusetts General Hospital	—
Completed	Onco-Vascular Exer-Study NCT06766903	Cristian Alvarez	N/A
Unknown	Prevalence of the Appearance of Diabetic Ulcers in Patients With 3D Insole and LSCI. NCT05843929	Esther Soler	N/A
Unknown	Identification of Biomarkers for the Study of the Diabetic Foot and Evolution. NCT05783700	Esther Soler	—
Unknown	Vascular Amputee Physical Performance Qualitative (VAmPP-Q) Study NCT05860764	University of Leicester	—
Completed	Inter-individual Physiological Response to a Training and Detraining Period in Cardiometabolic Risk Factors Su NCT05710653	Cristian Alvarez	N/A
Completed	Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System NCT04585763	Shockwave Medical, Inc.	N/A
Completed	Heparin-Binding Protein and Heparins NCT04146493	Halla Halldorsdottir	—
Completed	3 Month PHI PAD PoM Study NCT02135848	GlaxoSmithKline	Phase 2
Terminated	Prevention of Restenosis Following Revascularization NCT00518284	Celgene Corporation	Phase 2
Unknown	Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Peritec Peritoneal Lined Stent and Delivery NCT00542646	PeriTec Biosciences Ltd.	EARLY_Phase 1